EMA — authorised 31 December 2009
- Application: EMEA/H/C/000888
- Marketing authorisation holder: Pharmion Ltd.
- Local brand name: Orplatna
- Status: withdrawn
🇪🇺 SATRAPLATIN in European Union
EMA authorised SATRAPLATIN on 31 December 2009
Marketing authorisation
SATRAPLATIN in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is SATRAPLATIN approved in European Union?
Yes. EMA authorised it on 31 December 2009.
Who is the marketing authorisation holder for SATRAPLATIN in European Union?
Pharmion Ltd. holds the EU marketing authorisation.